RVU120

SEL120 · Ryvu Therapeutics SA

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RVU120, covering 2024-12-17 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis [Phase 2]